Medica Corp

MA - BedfordDiagnostics3 H-1B visas (FY2023)

Focus: Medica Corp is a diagnostics company founded in 1983 specializing in in-vitro diagnostic analyzers, headquartered in Bedford, MA. The company operates across multiple therapeutic areas including oncology, cardiovascular, neurology, immunology, and hematology.

Oncology Cardiovascular Neurology Immunology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

5 recent layoff filings (12 mo) — 421 affected

1/30/2026 — San Diego, CA · 83 affected · Layoff Permanent
1/7/2026 — Pomona, CA · 108 affected · Layoff Permanent
1/7/2026 — Claremont, CA · 1 affected · Layoff Permanent
+2 more

Source: state DOL filings via Big Local News

About Medica Corp

AI assessmentNot Hiring

No open roles listed right now. Follow Medica Corp to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthWatch

Pipeline

Early-stage

50 total

LOE Risk

1 imminent

CAMBIA

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

TYRVAYA

Smoking Cessation, Nicotine Dependence, Tobacco Use Disorder

$37M Part D

Peak

Help build intelligence for Medica Corp

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established 40-year-old company with a diversified product portfolio spanning oncology, cardiovascular, and neurology
Strong H1B sponsorship track record with 3 approvals and zero denials in 2023, indicating international talent investment
Multi-therapeutic platform positioning offers exposure to complex disease areas and specialized diagnostic development

Watch Out For

Heavy revenue concentration (32%) on single product TYRVAYA creates vulnerability to market competition and pricing pressure
Thin pipeline quality with mostly early-stage programs (Phase 1-2) and no clear near-term catalysts for major approvals
No active job openings reported, suggesting limited hiring velocity or potential organizational contraction

Generated by Claude from Medica Corp's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Core revenue driver at 32% of company total with 11+ year exclusivity runway; peak sales phase.

IMATINIB MESYLATE

Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST)

$57M Part D (combined)

Post-LOE

Post-patent portfolio stabilizer; generic competition erodes margins in oncology space.

CAMBIA

Post-Operative Pain, Ankle Sprain, Upper Respiratory Tract Infection

$2M Part D

LOE Approaching0.1yr

Imminent patent cliff in 2026 presents near-term revenue erosion risk; minimal revenue contribution.

ZIPSOR

Post-operative Pain, Fever, Sprains and Strains

$797K Part D

LOE Approaching2.7yr

Secondary patent cliff in 2029; niche pain management asset with limited market presence.

DIMETHYL FUMARATE

Relapsing forms of Multiple Sclerosis (MS)

$14M Part D

Pre-Launch

Pre-launch MS asset targeting neurology expansion; moderate revenue potential in competitive MS market.

Pipeline & Clinical Trials

ChitoCare® medical Wound Healing Gel

Dermatitis

N/A

Striatin

Malnourished Children

N/A

Hydrocortisone

Healthcare-Associated Pneumonia

N/A

Clinical Trials (1)

NCT05354778HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

N/A

antiviral therapies for CMV and/or ADV

Infectious Complications Following HSCT

N/A

Clinical Trials (1)

NCT02873325Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

N/A

Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who A

Breast Cancer

N/A

Clinical Trials (1)

NCT00776308Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery

N/A

magnetic facial nerve stimulation

Normal Subject / Healthy Volunteers

N/A

Clinical Trials (1)

NCT03487393VitalFlow Healthy Volunteer Study

N/A

Rotational fractional resection

Skin Laxity

N/A

Clinical Trials (1)

NCT03407313CONFORM: Rotational Fractional Resection for Submental Contouring

N/A

Symptomatology, Treatment. daily Activities and Anxiety for Cardiovascular patients Survey

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT04508920A Survey to Assess Effects of Covid-19 on Cardiovascular Patients

N/A

Screening in Myocardial Perfusion Patients

Breast Cancer

N/A

Clinical Trials (1)

NCT00943241Screening in Myocardial Perfusion Patients

N/A

HIBA-Institutional Registry of Amyloidosis

Amyloidosis

N/A

Clinical Trials (1)

NCT01347047HIBA-Institutional Registry of Amyloidosis

N/A

Glucose and lipids

Hyperlipidemia

N/A

Clinical Trials (1)

NCT02029989Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

N/A

Upadacitinib

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT05989932Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

N/A

Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma

Basal Cell Carcinoma

N/A

Clinical Trials (1)

NCT06309836Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma

N/A

Surgery with FACET FIXATION implants

Degenerative Lumbar Spinal Stenosis

N/A

Clinical Trials (1)

NCT05645497Evaluation of the Efficacy and Safety of the FACET FIXation Implant.

N/A

Motilis-3D-transit

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT01745029Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit

N/A

Pregabalin capsules 150 mg of Dexa Medica

Healthy

N/A

Motilis-3D transit

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT01752361Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit

N/A

Nasal swab

Inflammation

N/A

Clinical Trials (1)

NCT03311048Airway Inflammatory Profile Among Cleaning Workers From Different Workplaces

N/A

Surgery

Breast Cancer

N/A

Clinical Trials (1)

NCT06447532Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

N/A

Glimepiride

Chronic Heart Failure

N/A

Clinical Trials (1)

NCT05538819The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure

N/A

Treatment A

Perennial Allergic Rhinitis

N/A

Quikclot Radial

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03535597Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access

N/A

Lisinopril 10 mg tablets of PT Dexa Medica

Healthy

N/A

Dapagliflozin 10 mg film-coated tablet

Healthy

N/A

Individualized educational program

Asthma

N/A

Clinical Trials (1)

NCT03655392Clinical, Functional and Inflammatory Evaluation in Asthmatic Patients After a Simple Short-Term Educational Program

N/A

Mirabilis System

Uterine Leiomyoma

N/A

Clinical Trials (1)

NCT03219385Directed Ablation of Uterine Fibroids Using a Noninvasive Approach

N/A

Nutritional counseling

Overweight

N/A

Clinical Trials (1)

NCT02887950Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause

N/A

colonoscopy

Inflammatory Bowel Diseases

N/A

Clinical Trials (1)

NCT05576402Endoscopic Scoring System Utilization in Inflammatory Bowel Disease

N/A

Cardiac Contractility Modulation

Chagas Cardiomyopathy

N/A

CeraVe Moisturizing Cream

Atopic Dermatitis (AD)

N/A

Clinical Trials (1)

NCT07204561CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

N/A

topical treatment with the pre- and postbiotic study preparation and niacinamide 4% and one with the 10% urea-based preparation.

Xerosis Cutis

N/A

Clinical Trials (1)

NCT06868771Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR

N/A

Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

Breast Cancer

N/A

Clinical Trials (1)

NCT00943527Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

N/A

500 mg metformin hydrochloride extended release caplet

Metformin XR BE Study in Healthy Volunteers With Single and Multiple Dose

N/A

National Register of Moderate and Severe Adult Atopic Dermatitis

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT06313333National Register of Moderate and Severe Adult Atopic Dermatitis

N/A

Focal Contouring System

Skin Laxity

N/A

Clinical Trials (1)

NCT03853980The INFORM Study: Rotational Fractional Resection for Submental Contouring

N/A

quadrivalent subunit influenza vaccine

Influenza Vaccine

N/A

Low calorie diet treatment

Infertility

N/A

Clinical Trials (1)

NCT01566929Weight Management Intervention for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF)

N/A

Point of Care - Glycated Hemoglobin

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT05440968Comparative Effectiveness of POC-A1c vs the Current Standard Based on OGTT for Early Detection DM2 in Colombia

N/A

Mirabilis High-Intensity Focused Ultrasound Treatment System

Uterine Fibroids (Leiomyomas)

N/A

Clinical Trials (1)

NCT01946178Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids

N/A

Valsartan 160 mg film-coated caplets

Healthy

N/A

Rotational fractional resection

Skin Laxity

N/A

Clinical Trials (1)

NCT03966924The PREFORM Study: Rotational Fractional Resection for Submental Contouring

N/A

Non-pharmacological approach of insomnia

Insomnia

N/A

no interventions

Short Bowel Syndrome

N/A

Clinical Trials (1)

NCT04976075ImpRovE underSTanding of Short bOwel syndRome in Latin-amErica

N/A

Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT01384721Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease

N/A

18F-

Lung Cancer

N/A

Clinical Trials (1)

NCT035687994-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

N/A

Liquid Chromatography-Mass Spectrometry Method to identify bilirubin molecular species

Hepatic Encephalopathy

N/A

Clinical Trials (1)

NCT05566548Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure

N/A

ClorNovir®

COVID-19

N/A

cyclamax

Insomnia

N/A

Clinical Trials (1)

NCT00484497Evaluation of a Food Supplement on Sleep Quality

N/A

Perindopril 4 mg tablets of PT Dexa Medica

Healthy

N/A

data collection

Scabies

N/A

Clinical Trials (1)

NCT07305961National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 1983

Portfolio: 207 approved products, 131 clinical trials

Top TAs: Cardiovascular, Oncology, Respiratory

H-1B (2023): 3 approvals

Portfolio Health

Pre-Launch34 (16%)

Launch1 (0%)

Growth2 (1%)

Peak5 (2%)

LOE Approaching26 (13%)

Post-LOE139

Therapeutic Area Focus

Cardiovascular

44 marketed12 pipeline

Oncology

35 marketed17 pipeline

Respiratory

32 marketed15 pipeline

Neurology

30 marketed8 pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Risk Signals

WARN Act Layoff Notices (5)

2026-01-30

83 employees affected— San Diego, CA

source

2026-01-07

108 employees affected— Pomona, CA

source

INTRAVENOUS · INJECTABLE

Radiopharmaceutical Activity

16 marketed17 pipeline

Immunology

16 marketed6 pipeline

Metabolic Diseases

8 marketed12 pipeline

Hematology

10 marketed

2026-01-07

1 employees affected— Claremont, CA

source

2026-01-07

4 employees affected— Pomona, CA

source

2025-08-22

225 employees affected— Willows, CA

source

Source: state DOL filings, aggregated via Big Local News

1 active drug shortage

Lorazepam Injection shortage reported; no recent layoff notices documented.

Supply chain disruptions on non-core products; no major operational red flags but lack of transparency on employee headcount is concern.

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Medica Corp

About Medica Corp

Why Work Here

Key Products

Watch Out For

Products & Portfolio (60)

Key Products by Revenue

Other Products (53)

Pipeline & Clinical Trials

Open Jobs (0)

Visa Sponsorship

Risk Signals

WARN Act Layoff Notices (5)